Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CymaBay Therapeutics Inc announces pricing of public offering of common stock


Tuesday, 22 Jul 2014 08:00am EDT 

CymaBay Therapeutics Inc:Pricing of its follow-on public offering of 4,000,000 shares of its common stock at public offering price of $5.50 per share, before underwriting discounts and commissions.All of shares of common stock are being offered by CymaBay Therapeutics.In addition granted underwriters 30-day option to purchase up to an additional 600,000 shares of common stock at public offering price less the underwriting discounts and commissions to cover over-allotments, if any.Company's shares are traded on The NASDAQ Capital Market under the ticker symbol CBAY.Offering is expected to close on July 25 subject to customary closing conditions. 

Company Quote

8.41
0.17 +2.06%
19 Dec 2014